Auto-Immune Diseases Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4000
Buy Report Download FREE Resources

Published: November 27, 2024 Report Code: GDME1889EPD-ST

Select Item

Auto-Immune Diseases Pipeline Market Report Overview

Auto-immune disease diagnostic tests are used for the detection of autoimmune disorders by identifying auto-antibodies in the patient’s test sample. The auto-immune diseases pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Territories ·       The US

·       Europe

·       China

·       Canada

·       Singapore
Key Regulatory Paths ·       510(k)

·       CE-IVD

·       NMPA

·       MDL

·       HSA
Leading Companies ·       Aarhus University

·       Abreos Biosciences Inc

·       Adaptive Biotechnologies Corp

·       Albert Ludwigs University of Freiburg

·       Alere Inc
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Auto-Immune Diseases Pipeline Market Segmentation by Territories

A few of the key territories with the auto-immune diseases pipeline market are the US, China, Europe, Canada, and Singapore. As of November 2024, the US accounted for the highest number of pipeline products.

Auto-Immune Diseases Pipeline Market Analysis by Territories, 2024 (%)

Auto-Immune Diseases Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Auto-Immune Diseases Pipeline Market

Download a Free Report Sample

Auto-Immune Diseases Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the auto-immune diseases pipeline products market are 510(k), CE-IVD, NMPA, MDL, and HSA. As of November 2024, 510(k) was the most followed pathway for pipeline products in the auto-immune diseases market.

Auto-Immune Diseases Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Auto-Immune Diseases Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Auto-Immune Diseases Pipeline Market

Download a Free Report Sample

Auto-Immune Diseases Pipeline Market – Competitive Landscape

A few of the key companies associated with the auto-immune diseases pipeline market are Aarhus University, Abreos Biosciences Inc., Adaptive Biotechnologies Corp, Albert Ludwigs University of Freiburg, and Alere Inc., among others.

Aarhus University: Headquartered in Aarhus, Denmark, the university offers bachelor’s degrees, master’s degrees, and PhD programs in various disciplines. Aarhus operates through various departments in the areas of aesthetics and communication, agroecology, dentistry, and genetics and molecular biology, among others. The university also provides public sector consultancy services and has research collaborations with private companies and educational institutions.

Abreos Biosciences Inc.: It is a biotechnology company that develops laboratory-based and point-of-care (POC) assays and reagents for the precision dose monitoring of biologic drugs. Its Monator is a drug-monitoring test that provides physicians with vital information for the personalized treatment of multiple sclerosis using natalizumab. Abreos offers custom reagents to biopharmaceutical manufacturers and researchers for drug development life cycle pharmacokinetic studies, bio-purification, and personalized dosing of biologic drugs. Abreos is headquartered in La Jolla, California, the US.

Auto-Immune Diseases Pipeline Market Analysis by Companies, 2024

Auto-Immune Diseases Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Auto-Immune Diseases Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Auto-Immune Diseases Pipeline Market Territories Outlook (2024)

  • The US
  • China
  • Europe
  • Canada
  • Singapore

Auto-Immune Diseases Pipeline Market Regulatory Paths Outlook (2024)

  • 510(k)
  • CE-IVD
  • NMPA
  • MDL
  • HSA

Scope

This report provides:

  • Extensive coverage of the auto-immune diseases under development.

  • An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.

  • Reviews of major players involved in the development of auto-immune diseases and lists all their pipeline projects.

  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.

  • Key clinical trial data of ongoing clinical trials specific to pipeline products.

  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.

  • Identify and understand important and diverse types of auto-immune diseases under development.

  • Develop market-entry and market-expansion strategies.

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Aarhus University
Abreos Biosciences Inc
Adaptive Biotechnologies Corp
Albert Ludwigs University of Freiburg
Alere Inc
Amarantus Diagnostics Inc
apDia nv
Asylia Diagnostics BV
Autoimmune Technologies LLC
Avotres Inc
Beckman Coulter Inc
Bellvitge Biomedical Research Institute
BG Medicine Inc
Biogen Inc
BIOHOPE Scientific SL
Biomedal SL
Bionure Farma SL (Inactive)
BioShai Ltd
Biotome Pty Ltd
CDI Laboratories Inc
Celdara Medical LLC
Charite University Hospital of Berlin
Chronix Biomedical Inc
Cincinnati Children's Hospital Medical Center
Cizzle Biotechnology Holdings Plc
Co-Diagnostics Inc
Columbia University
Crescendo Bioscience Inc
Department of Biomedical Engineering Columbia University
Digna Biotech SL
DNAlytics SA
Enterome Bioscience SA
Exagen Diagnostics Inc
Exodus Biosciences LLC
Ezose Sciences Inc.
Flamentera AG
Genalyte Inc
GeNeuro SA
Grifols SA
Guangzhou Wondfo Biotech Co Ltd
Hannover Medical School
HealthTell Inc
Helmholtz Centre for Infection Research
HOB Biotech Group Suzhou Co Ltd
Hospital for Special Surgery
HTG Molecular Diagnostics Inc
Hycor Biomedical Inc
Ignyta Inc
Immunarray Pvt Ltd
Immunovia AB
ImmusanT Inc
Innobiochips
Inova Diagnostics Inc
InterVenn BioSciences
Iron Horse Diagnostics, Inc.
JJP Biologics Sp Zoo
Johns Hopkins University
Lankenau Institute for Medical Research
LineaGen Inc
Lophius Biosciences GmbH
Louisville Bioscience Inc (Inactive)
Max Delbruck Center for Molecular Medicine
Mayo Clinic
Medica Corp
Medical & Biological Laboratories Co Ltd
Metabiomics Corporation
Metabolomic Technologies Inc
Metabolon Inc
Metanomics Health GmbH
MSDx Inc
Myriad Genetics Inc
Nanosphere Inc (Inactive)
Neuro Vigor LLC
NoToPharm srl
Numares AG
OmniBiome Therapeutics Inc
One Way Liver SL
OPKO Health Inc
Op-T-Mune Inc
Oxford Biodynamics Plc
Oxford Gene Technology Ltd
Oxford Immunotec Ltd
Pearsanta Inc
Pediatric Bioscience LLC
Penn State College of Medicine
Prediction BioSciences SAS
Progentec Diagnostics Inc
Prometheus Biosciences Inc
Protagen AG
ProteinLogic Ltd
Psyros Diagnostics Ltd
Quanterix Corp
Rambam Health Care Campus
Rappaport Family Institute for Research in the Medical Science
Revvity Inc
Roche Diagnostics
Roche Diagnostics International Ltd
Royal College of Surgeons Ireland
Scailyte AG
Seattle Children's Hospital
Sengenics Corp LLC
Sequenom Inc
Shuwen Biotech Co Ltd
SomaLogic Inc
Southern Illinois University Carbondale
Spanish National Research Council
SQI Diagnostics Inc
Statens Serum Institut
Sugentech Inc
Svar Life Science AB
TBG Diagnostics Ltd
Tel Aviv University
The Chinese University of Hong Kong
The Walter and Eliza Hall Institute of Medical Research
Toscana Biomarkers Srl
University Health Network
University of Alberta
University of California Irvine
University of California San Francisco
University of Chicago
University of Colorado
University of Illinois at Chicago
University of Maryland Baltimore
University of Missouri
University of New South Wales
University of Oslo
University of Oxford
University of Pecs
US Biomarkers Inc
Veravas Inc
VolitionRX Ltd
Washington University in St Louis
WerfenLife SA
XEPTAGEN SpA
Yale University

Table of Contents

|1 Table of Contents

|1.1 List of Tables

|1.2 List of Figures

2 Introduction

2.1 Auto-Immune Diseases Overview

3 Products under Development

3.1 Auto-Immune Diseases – Pipeline Products by Stage of Development

3.2 Auto-Immune Diseases – Pipeline Products by Territory

3.3 Auto-Immune Diseases – Pipeline Products by Regulatory Path

3.4 Auto-Immune Diseases – Pipeline Products by Estimated Approval Date

3.5 Auto-Immune Diseases – Ongoing Clinical Trials

4 Auto-Immune Diseases – Pipeline Products under Development by Companies

4.1 Auto-Immune Diseases Companies – Pipeline Products by Stage of Development

4.2 Auto-Immune Diseases – Pipeline Products by Stage of Development

5 Auto-Immune Diseases Companies and Product Overview

5.1 Aarhus University Company Overview

5.1.1 Aarhus University Pipeline Products & Ongoing Clinical Trials Overview

5.2 Abreos Biosciences Inc Company Overview

5.2.1 Abreos Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview

5.3 Adaptive Biotechnologies Corp Company Overview

5.3.1 Adaptive Biotechnologies Corp Pipeline Products & Ongoing Clinical Trials Overview

5.4 Albert Ludwigs University of Freiburg Company Overview

5.4.1 Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview

5.5 Alere Inc Company Overview

5.5.1 Alere Inc Pipeline Products & Ongoing Clinical Trials Overview

5.6 Amarantus Diagnostics Inc Company Overview

5.6.1 Amarantus Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.7 apDia nv Company Overview

5.7.1 apDia nv Pipeline Products & Ongoing Clinical Trials Overview

5.8 Asylia Diagnostics BV Company Overview

5.8.1 Asylia Diagnostics BV Pipeline Products & Ongoing Clinical Trials Overview

5.9 Autoimmune Technologies LLC Company Overview

5.9.1 Autoimmune Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview

5.10 Avotres Inc Company Overview

5.10.1 Avotres Inc Pipeline Products & Ongoing Clinical Trials Overview

5.11 Beckman Coulter Inc Company Overview

5.11.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview

5.12 Bellvitge Biomedical Research Institute Company Overview

5.12.1 Bellvitge Biomedical Research Institute Pipeline Products & Ongoing Clinical Trials Overview

5.13 BG Medicine Inc Company Overview

5.13.1 BG Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview

5.14 Biogen Inc Company Overview

5.14.1 Biogen Inc Pipeline Products & Ongoing Clinical Trials Overview

5.15 BIOHOPE Scientific SL Company Overview

5.15.1 BIOHOPE Scientific SL Pipeline Products & Ongoing Clinical Trials Overview

5.16 Biomedal SL Company Overview

5.16.1 Biomedal SL Pipeline Products & Ongoing Clinical Trials Overview

5.17 Bionure Farma SL (Inactive) Company Overview

5.17.1 Bionure Farma SL (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.18 BioShai Ltd Company Overview

5.18.1 BioShai Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.19 Biotome Pty Ltd Company Overview

5.19.1 Biotome Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.20 CDI Laboratories Inc Company Overview

5.20.1 CDI Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview

5.21 Celdara Medical LLC Company Overview

5.21.1 Celdara Medical LLC Pipeline Products & Ongoing Clinical Trials Overview

5.22 Charite University Hospital of Berlin Company Overview

5.22.1 Charite University Hospital of Berlin Pipeline Products & Ongoing Clinical Trials Overview

5.23 Chronix Biomedical Inc Company Overview

5.23.1 Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.24 Cincinnati Children’s Hospital Medical Center Company Overview

5.24.1 Cincinnati Children’s Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview

5.25 Cizzle Biotechnology Holdings Plc Company Overview

5.25.1 Cizzle Biotechnology Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview

5.26 Co-Diagnostics Inc Company Overview

5.26.1 Co-Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.27 Columbia University Company Overview

5.27.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview

5.28 Crescendo Bioscience Inc Company Overview

5.28.1 Crescendo Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview

5.29 Department of Biomedical Engineering Columbia University Company Overview

5.29.1 Department of Biomedical Engineering Columbia University Pipeline Products & Ongoing Clinical Trials Overview

5.30 Digna Biotech SL Company Overview

5.30.1 Digna Biotech SL Pipeline Products & Ongoing Clinical Trials Overview

5.31 DNAlytics SA Company Overview

5.31.1 DNAlytics SA Pipeline Products & Ongoing Clinical Trials Overview

5.32 Enterome Bioscience SA Company Overview

5.32.1 Enterome Bioscience SA Pipeline Products & Ongoing Clinical Trials Overview

5.33 Exagen Diagnostics Inc Company Overview

5.33.1 Exagen Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.34 Exodus Biosciences LLC Company Overview

5.34.1 Exodus Biosciences LLC Pipeline Products & Ongoing Clinical Trials Overview

5.35 Ezose Sciences Inc. Company Overview

5.35.1 Ezose Sciences Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.36 Flamentera AG Company Overview

5.36.1 Flamentera AG Pipeline Products & Ongoing Clinical Trials Overview

5.37 Genalyte Inc Company Overview

5.37.1 Genalyte Inc Pipeline Products & Ongoing Clinical Trials Overview

5.38 GeNeuro SA Company Overview

5.38.1 GeNeuro SA Pipeline Products & Ongoing Clinical Trials Overview

5.39 Grifols SA Company Overview

5.39.1 Grifols SA Pipeline Products & Ongoing Clinical Trials Overview

5.40 Guangzhou Wondfo Biotech Co Ltd Company Overview

5.40.1 Guangzhou Wondfo Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.41 Hannover Medical School Company Overview

5.41.1 Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview

5.42 HealthTell Inc Company Overview

5.42.1 HealthTell Inc Pipeline Products & Ongoing Clinical Trials Overview

5.43 Helmholtz Centre for Infection Research Company Overview

5.43.1 Helmholtz Centre for Infection Research Pipeline Products & Ongoing Clinical Trials Overview

5.44 HOB Biotech Group Suzhou Co Ltd Company Overview

5.44.1 HOB Biotech Group Suzhou Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.45 Hospital for Special Surgery Company Overview

5.45.1 Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview

5.46 HTG Molecular Diagnostics Inc Company Overview

5.46.1 HTG Molecular Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.47 Hycor Biomedical Inc Company Overview

5.47.1 Hycor Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.48 Ignyta Inc Company Overview

5.48.1 Ignyta Inc Pipeline Products & Ongoing Clinical Trials Overview

5.49 Immunarray Pvt Ltd Company Overview

5.49.1 Immunarray Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.50 Immunovia AB Company Overview

5.50.1 Immunovia AB Pipeline Products & Ongoing Clinical Trials Overview

5.51 ImmusanT Inc Company Overview

5.51.1 ImmusanT Inc Pipeline Products & Ongoing Clinical Trials Overview

5.52 Innobiochips Company Overview

5.52.1 Innobiochips Pipeline Products & Ongoing Clinical Trials Overview

5.53 Inova Diagnostics Inc Company Overview

5.53.1 Inova Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.54 InterVenn BioSciences Company Overview

5.54.1 InterVenn BioSciences Pipeline Products & Ongoing Clinical Trials Overview

5.55 Iron Horse Diagnostics, Inc. Company Overview

5.55.1 Iron Horse Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.56 JJP Biologics Sp Zoo Company Overview

5.56.1 JJP Biologics Sp Zoo Pipeline Products & Ongoing Clinical Trials Overview

5.57 Johns Hopkins University Company Overview

5.57.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview

5.58 Lankenau Institute for Medical Research Company Overview

5.58.1 Lankenau Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview

5.59 LineaGen Inc Company Overview

5.59.1 LineaGen Inc Pipeline Products & Ongoing Clinical Trials Overview

5.60 Lophius Biosciences GmbH Company Overview

5.60.1 Lophius Biosciences GmbH Pipeline Products & Ongoing Clinical Trials Overview

5.61 Louisville Bioscience Inc (Inactive) Company Overview

5.61.1 Louisville Bioscience Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.62 Max Delbruck Center for Molecular Medicine Company Overview

5.62.1 Max Delbruck Center for Molecular Medicine Pipeline Products & Ongoing Clinical Trials Overview

5.63 Mayo Clinic Company Overview

5.63.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview

5.64 Medica Corp Company Overview

5.64.1 Medica Corp Pipeline Products & Ongoing Clinical Trials Overview

5.65 Medical & Biological Laboratories Co Ltd Company Overview

5.65.1 Medical & Biological Laboratories Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.66 Metabiomics Corporation Company Overview

5.66.1 Metabiomics Corporation Pipeline Products & Ongoing Clinical Trials Overview

5.67 Metabolomic Technologies Inc Company Overview

5.67.1 Metabolomic Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

5.68 Metabolon Inc Company Overview

5.68.1 Metabolon Inc Pipeline Products & Ongoing Clinical Trials Overview

5.69 Metanomics Health GmbH Company Overview

5.69.1 Metanomics Health GmbH Pipeline Products & Ongoing Clinical Trials Overview

5.70 MSDx Inc Company Overview

5.70.1 MSDx Inc Pipeline Products & Ongoing Clinical Trials Overview

5.71 Myriad Genetics Inc Company Overview

5.71.1 Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.72 Nanosphere Inc (Inactive) Company Overview

5.72.1 Nanosphere Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.73 Neuro Vigor LLC Company Overview

5.73.1 Neuro Vigor LLC Pipeline Products & Ongoing Clinical Trials Overview

5.74 NoToPharm srl Company Overview

5.74.1 NoToPharm srl Pipeline Products & Ongoing Clinical Trials Overview

5.75 Numares AG Company Overview

5.75.1 Numares AG Pipeline Products & Ongoing Clinical Trials Overview

5.76 OmniBiome Therapeutics Inc Company Overview

5.76.1 OmniBiome Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.77 One Way Liver SL Company Overview

5.77.1 One Way Liver SL Pipeline Products & Ongoing Clinical Trials Overview

5.78 OPKO Health Inc Company Overview

5.78.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview

5.79 Op-T-Mune Inc Company Overview

5.79.1 Op-T-Mune Inc Pipeline Products & Ongoing Clinical Trials Overview

5.80 Oxford Biodynamics Plc Company Overview

5.80.1 Oxford Biodynamics Plc Pipeline Products & Ongoing Clinical Trials Overview

5.81 Oxford Gene Technology Ltd Company Overview

5.81.1 Oxford Gene Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.82 Oxford Immunotec Ltd Company Overview

5.82.1 Oxford Immunotec Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.83 Pearsanta Inc Company Overview

5.83.1 Pearsanta Inc Pipeline Products & Ongoing Clinical Trials Overview

5.84 Pediatric Bioscience LLC Company Overview

5.84.1 Pediatric Bioscience LLC Pipeline Products & Ongoing Clinical Trials Overview

5.85 Penn State College of Medicine Company Overview

5.85.1 Penn State College of Medicine Pipeline Products & Ongoing Clinical Trials Overview

5.86 Prediction BioSciences SAS Company Overview

5.86.1 Prediction BioSciences SAS Pipeline Products & Ongoing Clinical Trials Overview

5.87 Progentec Diagnostics Inc Company Overview

5.87.1 Progentec Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.88 Prometheus Biosciences Inc Company Overview

5.88.1 Prometheus Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview

5.89 Protagen AG Company Overview

5.89.1 Protagen AG Pipeline Products & Ongoing Clinical Trials Overview

5.90 ProteinLogic Ltd Company Overview

5.90.1 ProteinLogic Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.91 Psyros Diagnostics Ltd Company Overview

5.91.1 Psyros Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.92 Quanterix Corp Company Overview

5.92.1 Quanterix Corp Pipeline Products & Ongoing Clinical Trials Overview

5.93 Rambam Health Care Campus Company Overview

5.93.1 Rambam Health Care Campus Pipeline Products & Ongoing Clinical Trials Overview

5.94 Rappaport Family Institute for Research in the Medical Science Company Overview

5.94.1 Rappaport Family Institute for Research in the Medical Science Pipeline Products & Ongoing Clinical Trials Overview

5.95 Revvity Inc Company Overview

5.95.1 Revvity Inc Pipeline Products & Ongoing Clinical Trials Overview

5.96 Roche Diagnostics Company Overview

5.96.1 Roche Diagnostics Pipeline Products & Ongoing Clinical Trials Overview

5.97 Roche Diagnostics International Ltd Company Overview

5.97.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.98 Royal College of Surgeons Ireland Company Overview

5.98.1 Royal College of Surgeons Ireland Pipeline Products & Ongoing Clinical Trials Overview

5.99 Scailyte AG Company Overview

5.99.1 Scailyte AG Pipeline Products & Ongoing Clinical Trials Overview

5.100 Seattle Children’s Hospital Company Overview

5.100.1 Seattle Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview

5.101 Sengenics Corp LLC Company Overview

5.101.1 Sengenics Corp LLC Pipeline Products & Ongoing Clinical Trials Overview

5.102 Sequenom Inc Company Overview

5.102.1 Sequenom Inc Pipeline Products & Ongoing Clinical Trials Overview

5.103 Shuwen Biotech Co Ltd Company Overview

5.103.1 Shuwen Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.104 SomaLogic Inc Company Overview

5.104.1 SomaLogic Inc Pipeline Products & Ongoing Clinical Trials Overview

5.105 Southern Illinois University Carbondale Company Overview

5.105.1 Southern Illinois University Carbondale Pipeline Products & Ongoing Clinical Trials Overview

5.106 Spanish National Research Council Company Overview

5.106.1 Spanish National Research Council Pipeline Products & Ongoing Clinical Trials Overview

5.107 SQI Diagnostics Inc Company Overview

5.107.1 SQI Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.108 Statens Serum Institut Company Overview

5.108.1 Statens Serum Institut Pipeline Products & Ongoing Clinical Trials Overview

5.109 Sugentech Inc Company Overview

5.109.1 Sugentech Inc Pipeline Products & Ongoing Clinical Trials Overview

5.110 Svar Life Science AB Company Overview

5.110.1 Svar Life Science AB Pipeline Products & Ongoing Clinical Trials Overview

5.111 TBG Diagnostics Ltd Company Overview

5.111.1 TBG Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.112 Tel Aviv University Company Overview

5.112.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview

5.113 The Chinese University of Hong Kong Company Overview

5.113.1 The Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview

5.114 The Walter and Eliza Hall Institute of Medical Research Company Overview

5.114.1 The Walter and Eliza Hall Institute of Medical Research Pipeline Products & Ongoing Clinical Trials Overview

5.115 Toscana Biomarkers Srl Company Overview

5.115.1 Toscana Biomarkers Srl Pipeline Products & Ongoing Clinical Trials Overview

5.116 University Health Network Company Overview

5.116.1 University Health Network Pipeline Products & Ongoing Clinical Trials Overview

5.117 University of Alberta Company Overview

5.117.1 University of Alberta Pipeline Products & Ongoing Clinical Trials Overview

5.118 University of California Irvine Company Overview

5.118.1 University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview

5.119 University of California San Francisco Company Overview

5.119.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview

5.120 University of Chicago Company Overview

5.120.1 University of Chicago Pipeline Products & Ongoing Clinical Trials Overview

5.121 University of Colorado Company Overview

5.121.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview

5.122 University of Illinois at Chicago Company Overview

5.122.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview

5.123 University of Maryland Baltimore Company Overview

5.123.1 University of Maryland Baltimore Pipeline Products & Ongoing Clinical Trials Overview

5.124 University of Missouri Company Overview

5.124.1 University of Missouri Pipeline Products & Ongoing Clinical Trials Overview

5.125 University of New South Wales Company Overview

5.125.1 University of New South Wales Pipeline Products & Ongoing Clinical Trials Overview

5.126 University of Oslo Company Overview

5.126.1 University of Oslo Pipeline Products & Ongoing Clinical Trials Overview

5.127 University of Oxford Company Overview

5.127.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview

5.128 University of Pecs Company Overview

5.128.1 University of Pecs Pipeline Products & Ongoing Clinical Trials Overview

5.129 US Biomarkers Inc Company Overview

5.129.1 US Biomarkers Inc Pipeline Products & Ongoing Clinical Trials Overview

5.130 Veravas Inc Company Overview

5.130.1 Veravas Inc Pipeline Products & Ongoing Clinical Trials Overview

5.131 VolitionRX Ltd Company Overview

5.131.1 VolitionRX Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.132 Washington University in St Louis Company Overview

5.132.1 Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview

5.133 WerfenLife SA Company Overview

5.133.1 WerfenLife SA Pipeline Products & Ongoing Clinical Trials Overview

5.134 XEPTAGEN SpA Company Overview

5.134.1 XEPTAGEN SpA Pipeline Products & Ongoing Clinical Trials Overview

5.135 Yale University Company Overview

5.135.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview

6 Auto-Immune Diseases- Recent Developments

6.1 Oct 23, 2024: Thermo Fisher Scientific Announces Q3 2024 Financial Results

6.2 Oct 21, 2024: Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence

6.3 Oct 03, 2024: Volition hosts NETs in sepsis management symposium at ESICM Lives 2024

6.4 Oct 01, 2024: Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 23, 2024

6.5 Sep 23, 2024: OPKO Health’s ModeX Therapeutics Names Giovanni Abbadessa as Chief Medical Officer

6.6 Sep 12, 2024: CareDx Appoints Keith Kennedy Chief Operating Officer and Jessica Meng Chief Commercial Officer

6.7 Sep 03, 2024: AliveDx Receives IVDR-CE Mark for Multiplexed Assay to Accurately Detect Celiac Disease (CD) on the MosaiQ System

6.8 Aug 22, 2024: ReAlta Life Sciences Invigorates Executive Team with Appointments of David Marek as Chief Executive Officer and Paolo Martini, Ph.D., as Chief Research and Development Officer

6.9 Aug 20, 2024: Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer

6.10 Aug 13, 2024: Trinity Biotech to Announce Q2 2024 Financial Results

6.11 Aug 05, 2024: Immunovia Publishes Interim Report for January-June 2024

6.12 Jul 15, 2024: Beckman Coulter Receives Additional 510(K) Clearance For Access Thyroglobulin Antibody II Assay

6.13 Jul 02, 2024: Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 24, 2024

6.14 Jun 17, 2024: Thermo Fisher Scientific Showcases Clinical Research Innovation at DIA Annual Meeting

6.15 Jun 13, 2024: Scipher Medicine Showcases New Data at EULAR 2024

6.16 May 30, 2024: Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area

6.17 May 29, 2024: Octave Bioscience, Announces Publication in Nature Communications

6.18 May 21, 2024: Immunovia Notice of Annual General Meeting

6.19 May 07, 2024: Siemens Healthineers on Track to Meet Fiscal Year 2024 Targets After Second Quarter

6.20 Mar 18, 2024: Siemens Healthineers Intends to Close Fast Track Diagnostics

6.21 Feb 27, 2024: CareDx to Participate in the Raymond James & Associates’ 45th Annual Institutional Investors Conference

6.22 Feb 21, 2024: Myriad Genetics to Release Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024

6.23 Feb 07, 2024: Trinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA Code

6.24 Jan 03, 2024: Myriad Genetics to Present at 42nd Annual J.P. Morgan Healthcare Conference

6.25 Jan 02, 2024: Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan’s 42nd Annual Healthcare Conference

6.26 Dec 13, 2023: Thermo Fisher Scientific Signs Long-Term, Exclusive U.S. Distributor Agreement With Aesku.Group for IFA Testing Kits & Instruments

6.27 Nov 28, 2023: Quest Diagnostics and Scipher Medicine Collaborate to Scale Precision Medicine Access for Patients with Rheumatoid Arthritis

6.28 Nov 28, 2023: Thermo Fisher Scientific Prices Offering Of $2.5 Bln Of Senior Notes

7 Appendix

7.1 Methodology

7.2 About GlobalData

7.3 Contact Us

7.4 Disclaimer

Table

Auto-Immune Diseases – Pipeline Products by Stage of Development

Auto-Immune Diseases – Pipeline Products by Territory

Auto-Immune Diseases – Pipeline Products by Regulatory Path

Auto-Immune Diseases – Pipeline Products by Estimated Approval Date

Auto-Immune Diseases – Ongoing Clinical Trials

Auto-Immune Diseases Companies – Pipeline Products by Stage of Development

Auto-Immune Diseases – Pipeline Products by Stage of Development

Aarhus University Pipeline Products & Ongoing Clinical Trials Overview

Biomarker Test – Autoimmune Diseases – Product Status

Biomarker Test – Autoimmune Diseases – Product Description

Biomarker Test – Multiple Sclerosis – Product Status

Biomarker Test – Multiple Sclerosis – Product Description

Abreos Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview

Veritope Lateral Flow Immunoassay – Adalimumab – Product Status

Veritope Lateral Flow Immunoassay – Adalimumab – Product Description

Veritope Lateral Flow Immunoassay – Infliximab – Product Status

Veritope Lateral Flow Immunoassay – Infliximab – Product Description

Adaptive Biotechnologies Corp Pipeline Products & Ongoing Clinical Trials Overview

Non-Invasive Diagnostic Test – Celiac Disease – Product Status

Non-Invasive Diagnostic Test – Celiac Disease – Product Description

T-Detect – Multiple Sclerosis – Product Status

T-Detect – Multiple Sclerosis – Product Description

T-Detect – Rheumatoid Arthritis – Product Status

T-Detect – Rheumatoid Arthritis – Product Description

T-Detect – Ulcerative Colitis – Product Status

T-Detect – Ulcerative Colitis – Product Description

Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview

Biomarker Based Assay – Systemic Sclerosis – Product Status

Biomarker Based Assay – Systemic Sclerosis – Product Description

Alere Inc Pipeline Products & Ongoing Clinical Trials Overview

AIMS System – Cardiolipin IgG Test – Product Status

AIMS System – Cardiolipin IgG Test – Product Description

AtheNA Multi-Lyte System – Cardiolipin IgG Test – Product Status

AtheNA Multi-Lyte System – Cardiolipin IgG Test – Product Description

Amarantus Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Assay – Neuromyelitis Optica – Product Status

Diagnostic Assay – Neuromyelitis Optica – Product Description

Diagnostic Assay – Paraneoplastic Disease – Product Status

Diagnostic Assay – Paraneoplastic Disease – Product Description

apDia nv Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Test – MS (Multiple Sclerosis) – Product Status

Diagnostic Test – MS (Multiple Sclerosis) – Product Description

Asylia Diagnostics BV Pipeline Products & Ongoing Clinical Trials Overview

CDx Assay – Systemic Lupus Erythematosus – Product Status

CDx Assay – Systemic Lupus Erythematosus – Product Description

CDx Assay – Systemic Sclerosis (SS) – Product Status

CDx Assay – Systemic Sclerosis (SS) – Product Description

Autoimmune Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview

Anti-Squalene Antibody Assay – Gulf War Syndrome – Product Status

Anti-Squalene Antibody Assay – Gulf War Syndrome – Product Description

Autoimmune Disease Virus Assay – Grave’s Disease – Product Status

Autoimmune Disease Virus Assay – Grave’s Disease – Product Description

Autoimmune Disease Virus Assay – Juvenile Rheumatoid Arthritis – Product Status

Autoimmune Disease Virus Assay – Juvenile Rheumatoid Arthritis – Product Description

Autoimmune Disease Virus Assay – Sjogren Syndrome – Product Status

Autoimmune Disease Virus Assay – Sjogren Syndrome – Product Description

Autoimmune Disease Virus Assay – Systemic Lupus Erythematosus – Product Status

Autoimmune Disease Virus Assay – Systemic Lupus Erythematosus – Product Description

Avotres Inc Pipeline Products & Ongoing Clinical Trials Overview

AVT-Dx001 – Product Status

AVT-Dx001 – Product Description

Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview

SYNCHRON LXi 725 Anti-dsDNA Assay – Product Status

SYNCHRON LXi 725 Anti-dsDNA Assay – Product Description

Bellvitge Biomedical Research Institute Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Device – Autoimmune Encephalitis – Product Status

Diagnostic Device – Autoimmune Encephalitis – Product Description

BG Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Assay – Multiple Sclerosis – Product Status

Diagnostic Assay – Multiple Sclerosis – Product Description

Biogen Inc Pipeline Products & Ongoing Clinical Trials Overview

Companion Diagnostic Test – Sjogren’s Syndrome – Product Status

Companion Diagnostic Test – Sjogren’s Syndrome – Product Description

BIOHOPE Scientific SL Pipeline Products & Ongoing Clinical Trials Overview

Immunobiogram – Lupus – Product Status

Immunobiogram – Lupus – Product Description

Immunobiogram – Psoriasis – Product Status

Immunobiogram – Psoriasis – Product Description

Biomedal SL Pipeline Products & Ongoing Clinical Trials Overview

ELISA DELIAC GFD – Product Status

ELISA DELIAC GFD – Product Description

Stick DELIAC GFD – Product Status

Stick DELIAC GFD – Product Description

Bionure Farma SL (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

BN – 301 Diagnostic/Prognostic Test – Product Status

BN – 301 Diagnostic/Prognostic Test – Product Description

BioShai Ltd Pipeline Products & Ongoing Clinical Trials Overview

PDx Prognostic Test – Product Status

PDx Prognostic Test – Product Description

PDx Screening Test – Product Status

PDx Screening Test – Product Description

PDx Test – Product Status

PDx Test – Product Description

Biotome Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview

Biomarker-Based Diagnostic Test – Acute Rheumatic Fever – Product Status

Biomarker-Based Diagnostic Test – Acute Rheumatic Fever – Product Description

CDI Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Test – Systemic Lupus Erythematosus – Product Status

Diagnostic Test – Systemic Lupus Erythematosus – Product Description

Celdara Medical LLC Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Assay – Diabetes – Product Status

Diagnostic Assay – Diabetes – Product Description

Charite University Hospital of Berlin Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Test – Celiac Disease – Product Status

Diagnostic Test – Celiac Disease – Product Description

Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview

Companion Diagnostic Test – Multiple Sclerosis – Product Status

Companion Diagnostic Test – Multiple Sclerosis – Product Description

Diagnostic Test – Systemic Lupus Erythematous – Product Status

Diagnostic Test – Systemic Lupus Erythematous – Product Description

Cincinnati Children’s Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview

Biomarker Panel – Lupus Nephritis – Product Status

Biomarker Panel – Lupus Nephritis – Product Description

Cizzle Biotechnology Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview

Companion Diagnostic Test – Autoimmune Disease – Product Status

Companion Diagnostic Test – Autoimmune Disease – Product Description

Co-Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Test – Auto-immune Disorder – Product Status

Diagnostic Test – Auto-immune Disorder – Product Description

Columbia University Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Assay – NCGS/NCWS – Product Status

Diagnostic Assay – NCGS/NCWS – Product Description

Crescendo Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview

Multi-Biomarker Test – Ankylosing Spondylitis – Product Status

Multi-Biomarker Test – Ankylosing Spondylitis – Product Description

Multi-Biomarker Test – Autoimmune Diseases – Product Status

Multi-Biomarker Test – Autoimmune Diseases – Product Description

Multi-Biomarker Test – Psoriatic Arthritis – Product Status

Multi-Biomarker Test – Psoriatic Arthritis – Product Description

Multi-Biomarker Test – Systemic Lupus Erythematosus – Product Status

Multi-Biomarker Test – Systemic Lupus Erythematosus – Product Description

Department of Biomedical Engineering Columbia University Pipeline Products & Ongoing Clinical Trials Overview

AutoDetect – Autoimmune Lupus Mediated Myocarditis – Product Status

AutoDetect – Autoimmune Lupus Mediated Myocarditis – Product Description

Digna Biotech SL Pipeline Products & Ongoing Clinical Trials Overview

Anti-CD-137 Antibodies Assay – Product Status

Anti-CD-137 Antibodies Assay – Product Description

Prognostic Test – Multiple Sclerosis – Product Status

Prognostic Test – Multiple Sclerosis – Product Description

DNAlytics SA Pipeline Products & Ongoing Clinical Trials Overview

RheumaKit-Tx – Product Status

RheumaKit-Tx – Product Description

Enterome Bioscience SA Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Test – Multiple Sclerosis – Product Status

Diagnostic Test – Multiple Sclerosis – Product Description

Diagnostic Test – Type 2 Diabetes – Product Status

Diagnostic Test – Type 2 Diabetes – Product Description

Exagen Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

AVISE RA Dx – Product Status

AVISE RA Dx – Product Description

AVISE RA Monitoring Device – Product Status

AVISE RA Monitoring Device – Product Description

AVISE RA Prognostic Device – Product Status

AVISE RA Prognostic Device – Product Description

AVISE SLE Monitor Plus – Product Status

AVISE SLE Monitor Plus – Product Description

Exodus Biosciences LLC Pipeline Products & Ongoing Clinical Trials Overview

AIMS – Product Status

AIMS – Product Description

Ezose Sciences Inc. Pipeline Products & Ongoing Clinical Trials Overview

Biomarker Diagnostic Assay – Multiple Sclerosis – Product Status

Biomarker Diagnostic Assay – Multiple Sclerosis – Product Description

Flamentera AG Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Test – Celiac Disease – Product Status

Diagnostic Test – Celiac Disease – Product Description

Genalyte Inc Pipeline Products & Ongoing Clinical Trials Overview

Maverick ANA 11 Assay Kit – Product Status

Maverick ANA 11 Assay Kit – Product Description

GeNeuro SA Pipeline Products & Ongoing Clinical Trials Overview

MSRV-Env Based Diagnostic Test – Multiple Sclerosis – Product Status

MSRV-Env Based Diagnostic Test – Multiple Sclerosis – Product Description

Grifols SA Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Test – Autoimmune Diseases – Product Status

Diagnostic Test – Autoimmune Diseases – Product Description

Guangzhou Wondfo Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Finecare Diagnostic Assay – Anti-CCP – Product Status

Finecare Diagnostic Assay – Anti-CCP – Product Description

Finecare Diagnostic Assay – RF – Product Status

Finecare Diagnostic Assay – RF – Product Description

Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Test – Multiple Sclerosis – Product Status

Diagnostic Test – Multiple Sclerosis – Product Description

HealthTell Inc Pipeline Products & Ongoing Clinical Trials Overview

ImmunoSignature Test – Dermatomyositis – Product Status

ImmunoSignature Test – Dermatomyositis – Product Description

ImmunoSignature Test – Multiple Sclerosis – Product Status

ImmunoSignature Test – Multiple Sclerosis – Product Description

ImmunoSignature Test – Rheumatoid Arthritis – Product Status

ImmunoSignature Test – Rheumatoid Arthritis – Product Description

ImmunoSignature Test – Scleroderma – Product Status

ImmunoSignature Test – Scleroderma – Product Description

ImmunoSignature Test – Sjogren’s Syndrome – Product Status

ImmunoSignature Test – Sjogren’s Syndrome – Product Description

ImmunoSignature Test – SLE Differential Dx – Product Status

ImmunoSignature Test – SLE Differential Dx – Product Description

ImmunoSignature Test – SLE-Disease Activity/Flare – Product Status

ImmunoSignature Test – SLE-Disease Activity/Flare – Product Description

ImmunoSignature Test – Ulcerative Colitis – Product Status

ImmunoSignature Test – Ulcerative Colitis – Product Description

Helmholtz Centre for Infection Research Pipeline Products & Ongoing Clinical Trials Overview

ELISA Based Assay – Rheumatic Fever – Product Status

ELISA Based Assay – Rheumatic Fever – Product Description

HOB Biotech Group Suzhou Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

HOB Biotech Diagnostic Assay – Auto-immunity – Product Status

HOB Biotech Diagnostic Assay – Auto-immunity – Product Description

Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview

Biomarker Test – Systemic Lupus Erythematosus – Product Status

Biomarker Test – Systemic Lupus Erythematosus – Product Description

HTG Molecular Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

NGS-Based Theranostic Tool – Product Status

NGS-Based Theranostic Tool – Product Description

Hycor Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview

HYTEC 288 PLUS – Centromere Test – Product Status

HYTEC 288 PLUS – Centromere Test – Product Description

HYTEC 288 PLUS – ANCA Profile Test – Product Status

HYTEC 288 PLUS – ANCA Profile Test – Product Description

Ignyta Inc Pipeline Products & Ongoing Clinical Trials Overview

TrailblazeDx Test – Systemic Lupus Erythematosus – Product Status

TrailblazeDx Test – Systemic Lupus Erythematosus – Product Description

TrailblazeTx Test – SLE (Systemic Lupus Erythematosus) – Product Status

TrailblazeTx Test – SLE (Systemic Lupus Erythematosus) – Product Description

Immunarray Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Test – Multiple Sclerosis – Product Status

Diagnostic Test – Multiple Sclerosis – Product Description

Immunovia AB Pipeline Products & Ongoing Clinical Trials Overview

IMMray Primary Sjogren’s Syndrome Assay – Product Status

IMMray Primary Sjogren’s Syndrome Assay – Product Description

IMMray Rheumatoid Arthritis Assay – Product Status

IMMray Rheumatoid Arthritis Assay – Product Description

IMMray SLE-d Test – Product Status

IMMray SLE-d Test – Product Description

IMMray Systemic Vasculitis Assay – Product Status

IMMray Systemic Vasculitis Assay – Product Description

ImmusanT Inc Pipeline Products & Ongoing Clinical Trials Overview

Nexvax2 Companion Diagnostic Test – Product Status

Nexvax2 Companion Diagnostic Test – Product Description

Serology Test – Celiac Disease – Product Status

Serology Test – Celiac Disease – Product Description

Innobiochips Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Assay – Autoimmune Diseases – Product Status

Diagnostic Assay – Autoimmune Diseases – Product Description

Inova Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

BIO-FLASH – Chromatin Assay – Product Status

BIO-FLASH – Chromatin Assay – Product Description

BIO-FLASH – sp100 Assay – Product Status

BIO-FLASH – sp100 Assay – Product Description

Biomarker Test – Autoimmune Liver Disease – Product Status

Biomarker Test – Autoimmune Liver Disease – Product Description

InterVenn BioSciences Pipeline Products & Ongoing Clinical Trials Overview

Treatment Monitoring Panel – Autoimmune Diseases – Product Status

Treatment Monitoring Panel – Autoimmune Diseases – Product Description

Iron Horse Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview

ALS Biologic Prognostic Test – Product Status

ALS Biologic Prognostic Test – Product Description

Multiple Sclerosis Disease Activity/Treatment Response Test – Product Status

Multiple Sclerosis Disease Activity/Treatment Response Test – Product Description

JJP Biologics Sp Zoo Pipeline Products & Ongoing Clinical Trials Overview

Companion Diagnostic Test – JJP-1212 – Product Status

Companion Diagnostic Test – JJP-1212 – Product Description

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview

Biomarker Based Diagnostic Assay – Multiple Sclerosis – Product Status

Biomarker Based Diagnostic Assay – Multiple Sclerosis – Product Description

Lankenau Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview

ANRE Assay – Product Status

ANRE Assay – Product Description

LineaGen Inc Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Test – Multiple Sclerosis – Product Status

Diagnostic Test – Multiple Sclerosis – Product Description

Lophius Biosciences GmbH Pipeline Products & Ongoing Clinical Trials Overview

T-Track Multiple Sclerosis – Product Status

T-Track Multiple Sclerosis – Product Description

Louisville Bioscience Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Lupus pT Autoimmune Test – Product Status

Lupus pT Autoimmune Test – Product Description

Multiple Sclerosis pT Autoimmune Test – Product Status

Multiple Sclerosis pT Autoimmune Test – Product Description

Polymyositis pT Autoimmune Test – Product Status

Polymyositis pT Autoimmune Test – Product Description

Scleroderma pT Autoimmune Test – Product Status

Scleroderma pT Autoimmune Test – Product Description

Max Delbruck Center for Molecular Medicine Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Test – Raynaud’s Syndrome – Product Status

Diagnostic Test – Raynaud’s Syndrome – Product Description

Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview

Antibody Test – Multiple Sclerosis – Product Status

Antibody Test – Multiple Sclerosis – Product Description

Medica Corp Pipeline Products & Ongoing Clinical Trials Overview

EasyRA Analyzer – IgA Assay – Product Status

EasyRA Analyzer – IgA Assay – Product Description

EasyRA Analyzer – IgG Assay – Product Status

EasyRA Analyzer – IgG Assay – Product Description

EasyRA Analyzer – IgM Assay – Product Status

EasyRA Analyzer – IgM Assay – Product Description

Medical & Biological Laboratories Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Anti-CADM-140 Autoantibodies Detection Kit – Product Status

Anti-CADM-140 Autoantibodies Detection Kit – Product Description

Metabiomics Corporation Pipeline Products & Ongoing Clinical Trials Overview

Microbiome Biomarker Test – Autoimmune Diseases – Product Status

Microbiome Biomarker Test – Autoimmune Diseases – Product Description

Microbiome Biomarker Test – Colitis – Product Status

Microbiome Biomarker Test – Colitis – Product Description

Microbiome Biomarker Test – Crohn’s Disease – Product Status

Microbiome Biomarker Test – Crohn’s Disease – Product Description

Metabolomic Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

CeliacDx – Product Status

CeliacDx – Product Description

ColitisDx – Product Status

ColitisDx – Product Description

CrohnsDx – Product Status

CrohnsDx – Product Description

IBDDx – Product Status

IBDDx – Product Description

Metabolon Inc Pipeline Products & Ongoing Clinical Trials Overview

Biomarker Test – Parkinson’s Disease – Product Status

Biomarker Test – Parkinson’s Disease – Product Description

Metanomics Health GmbH Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Assay – Multiple Sclerosis – Product Status

Diagnostic Assay – Multiple Sclerosis – Product Description

MSDx Inc Pipeline Products & Ongoing Clinical Trials Overview

Window Into The Brain Test Panel – Multiple Sclerosis – Product Status

Window Into The Brain Test Panel – Multiple Sclerosis – Product Description

Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Assay – Juvenile Idiopathic Rheumatoid Arthritis – Product Status

Diagnostic Assay – Juvenile Idiopathic Rheumatoid Arthritis – Product Description

Nanosphere Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Ultra-Sensitive Protein Assay – Autoimmune Disease – Product Status

Ultra-Sensitive Protein Assay – Autoimmune Disease – Product Description

Neuro Vigor LLC Pipeline Products & Ongoing Clinical Trials Overview

Acrolein Based Companion Diagnostic Assay – Multiple Sclerosis – Product Status

Acrolein Based Companion Diagnostic Assay – Multiple Sclerosis – Product Description

NoToPharm srl Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Assay – Dermatomyositis – Product Status

Diagnostic Assay – Dermatomyositis – Product Description

Diagnostic Assay – Mixed Connectivitis – Product Status

Diagnostic Assay – Mixed Connectivitis – Product Description

Diagnostic Assay – Polimyositis – Product Status

Diagnostic Assay – Polimyositis – Product Description

Diagnostic Assay – Sjogren Syndrome – Product Status

Diagnostic Assay – Sjogren Syndrome – Product Description

Diagnostic Assay – Systemic Lupus Erythematosus – Product Status

Diagnostic Assay – Systemic Lupus Erythematosus – Product Description

Diagnostic Assay – Systemic Sclerosis – Product Status

Diagnostic Assay – Systemic Sclerosis – Product Description

IFI16Ab Based Prognostic Assay – Product Status

IFI16Ab Based Prognostic Assay – Product Description

Numares AG Pipeline Products & Ongoing Clinical Trials Overview

Axinon – Multiple Sclerosis – Product Status

Axinon – Multiple Sclerosis – Product Description

OmniBiome Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

Pediatric Diagnostic Test – Autoimmune Disease – Product Status

Pediatric Diagnostic Test – Autoimmune Disease – Product Description

One Way Liver SL Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Test – Multiple Sclerosis – Product Status

Diagnostic Test – Multiple Sclerosis – Product Description

OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Test – Multiple Sclerosis – Product Status

Diagnostic Test – Multiple Sclerosis – Product Description

Op-T-Mune Inc Pipeline Products & Ongoing Clinical Trials Overview

Screening Test – Multiple Sclerosis – Product Status

Screening Test – Multiple Sclerosis – Product Description

Oxford Biodynamics Plc Pipeline Products & Ongoing Clinical Trials Overview

EpiSwitch T2DM Prognostic Test – Product Status

EpiSwitch T2DM Prognostic Test – Product Description

Oxford Gene Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview

OGT SLE Test – Product Status

OGT SLE Test – Product Description

Oxford Immunotec Ltd Pipeline Products & Ongoing Clinical Trials Overview

Stratokine – Product Status

Stratokine – Product Description

Pearsanta Inc Pipeline Products & Ongoing Clinical Trials Overview

AditxtScore – Autoimmune Diseases – Product Status

AditxtScore – Autoimmune Diseases – Product Description

Pediatric Bioscience LLC Pipeline Products & Ongoing Clinical Trials Overview

MAR Test – Product Status

MAR Test – Product Description

Penn State College of Medicine Pipeline Products & Ongoing Clinical Trials Overview

Multiple Sclerosis Biomarker Test – Product Status

Multiple Sclerosis Biomarker Test – Product Description

Prediction BioSciences SAS Pipeline Products & Ongoing Clinical Trials Overview

GenoPredicta – AutoImmune Disorder – Product Status

GenoPredicta – AutoImmune Disorder – Product Description

Progentec Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

aiMS DX Disease Activity Test – Multiple Sclerosis – Product Status

aiMS DX Disease Activity Test – Multiple Sclerosis – Product Description

aiMS DX Interferon Treatment Response – Multiple Sclerosis – Product Status

aiMS DX Interferon Treatment Response – Multiple Sclerosis – Product Description

aiMS DX NMO Distinction – Neuromyelitis Optica – Product Status

aiMS DX NMO Distinction – Neuromyelitis Optica – Product Description

aiMS DX Relapse Prediction Test – Multiple Sclerosis – Product Status

aiMS DX Relapse Prediction Test – Multiple Sclerosis – Product Description

aiSLE DX Classification Test – Product Status

aiSLE DX Classification Test – Product Description

aiSLE DX Disease Activity Test – Product Status

aiSLE DX Disease Activity Test – Product Description

Biologic Biomarker – Crohn’s Disease / Ulcerative Colitis – Product Status

Biologic Biomarker – Crohn’s Disease / Ulcerative Colitis – Product Description

Diagnostic Test – Sjogren’s Syndrome – Product Status

Diagnostic Test – Sjogren’s Syndrome – Product Description

Prometheus Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview

Companion Diagnostic Assay – Ulcerative Colitis – Product Status

Companion Diagnostic Assay – Ulcerative Colitis – Product Description

PRA052 Companion Diagnostic Assay – Product Status

PRA052 Companion Diagnostic Assay – Product Description

Prometheus Biosciences Inc – Ongoing Clinical Trials Overview

Companion Diagnostic Assay – Ulcerative Colitis – A Phase 2, Multi-center, Double-blind, Placebo-controlled Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Induction Therapy with PRA023 in Subjects with Moderately to Severely Active Ulcerative Colitis

Protagen AG Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Assay – Ankylosing Spondylitis – Product Status

Diagnostic Assay – Ankylosing Spondylitis – Product Description

Diagnostic Assay – Juvenile Idiopathic Arthritis – Product Status

Diagnostic Assay – Juvenile Idiopathic Arthritis – Product Description

Diagnostic Assay – Multiple Sclerosis – Product Status

Diagnostic Assay – Multiple Sclerosis – Product Description

Diagnostic Assay – Neuromyelitis Optica – Product Status

Diagnostic Assay – Neuromyelitis Optica – Product Description

Multilisa SLE – Product Status

Multilisa SLE – Product Description

Multiplex Assay – Autoimmune Diseases – Product Status

Multiplex Assay – Autoimmune Diseases – Product Description

NavigAID – Sjogren’s Syndrome – Product Status

NavigAID – Sjogren’s Syndrome – Product Description

ProteinLogic Ltd Pipeline Products & Ongoing Clinical Trials Overview

ImmiPrint Diagnostic Test – Autoimmune Diseases – Product Status

ImmiPrint Diagnostic Test – Autoimmune Diseases – Product Description

Psyros Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview

Psyros – Autoimmune Disease – Product Status

Psyros – Autoimmune Disease – Product Description

Quanterix Corp Pipeline Products & Ongoing Clinical Trials Overview

ADVIA Centaur sNFL Assay – Multiple Sclerosis – Product Status

ADVIA Centaur sNFL Assay – Multiple Sclerosis – Product Description

Digital ELISA – Crohn’s Disease – Product Status

Digital ELISA – Crohn’s Disease – Product Description

Rambam Health Care Campus Pipeline Products & Ongoing Clinical Trials Overview

Molecular Diagnostic Test – Multiple Sclerosis – Product Status

Molecular Diagnostic Test – Multiple Sclerosis – Product Description

Rappaport Family Institute for Research in the Medical Science Pipeline Products & Ongoing Clinical Trials Overview

Biomarker Test – Multiple Sclerosis – Product Status

Biomarker Test – Multiple Sclerosis – Product Description

Revvity Inc Pipeline Products & Ongoing Clinical Trials Overview

Accentis – Autoimmune Disorders – Product Status

Accentis – Autoimmune Disorders – Product Description

Roche Diagnostics Pipeline Products & Ongoing Clinical Trials Overview

Roche Elecsys NfL Test – Product Status

Roche Elecsys NfL Test – Product Description

Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview

Anti-IL17 Mab Companion Diagnostic Assay – Product Status

Anti-IL17 Mab Companion Diagnostic Assay – Product Description

Companion Diagnostic Test – Ocrelizumab – Product Status

Companion Diagnostic Test – Ocrelizumab – Product Description

IFN-Induced Genes Companion Diagnostic Test – Product Status

IFN-Induced Genes Companion Diagnostic Test – Product Description

Integrated Modular Analytics – IL-6 Test – Product Status

Integrated Modular Analytics – IL-6 Test – Product Description

Royal College of Surgeons Ireland Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Biomarker Assay – Maturity-Onset Of Diabetes Of The Young – Product Status

Diagnostic Biomarker Assay – Maturity-Onset Of Diabetes Of The Young – Product Description

Scailyte AG Pipeline Products & Ongoing Clinical Trials Overview

Companion Diagnostic Test – Autoimmunity – Product Status

Companion Diagnostic Test – Autoimmunity – Product Description

Seattle Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview

Biomarker Test – Juvenile Systemic Sclerosis – Product Status

Biomarker Test – Juvenile Systemic Sclerosis – Product Description

Genetic Test – Kawasaki Disease – Product Status

Genetic Test – Kawasaki Disease – Product Description

Sengenics Corp LLC Pipeline Products & Ongoing Clinical Trials Overview

Companion Diagnostic Test – Autoimmune Disease Drug 1 – Product Status

Companion Diagnostic Test – Autoimmune Disease Drug 1 – Product Description

Companion Diagnostic Test – Autoimmune Disease Drug 2 – Product Status

Companion Diagnostic Test – Autoimmune Disease Drug 2 – Product Description

Diagnostic Assay – Rheumatoid Arthritis – Product Status

Diagnostic Assay – Rheumatoid Arthritis – Product Description

Diagnostic Assay – Sjogren Syndrome – Product Status

Diagnostic Assay – Sjogren Syndrome – Product Description

Diagnostic Assay – Systemic Lupus Erythematosus – Product Status

Diagnostic Assay – Systemic Lupus Erythematosus – Product Description

Sequenom Inc Pipeline Products & Ongoing Clinical Trials Overview

AttoSense Lupus Panel – Product Status

AttoSense Lupus Panel – Product Description

Shuwen Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Test – Autoimmune Diseases – Product Status

Diagnostic Test – Autoimmune Diseases – Product Description

SomaLogic Inc Pipeline Products & Ongoing Clinical Trials Overview

SomaSignal Test – Multiple Sclerosis – Product Status

SomaSignal Test – Multiple Sclerosis – Product Description

Southern Illinois University Carbondale Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Test – Crohn’s Disease – Product Status

Diagnostic Test – Crohn’s Disease – Product Description

Diagnostic Test – Ulcerative Colitis – Product Status

Diagnostic Test – Ulcerative Colitis – Product Description

Spanish National Research Council Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Assay – Rheumatoid Arthritis – Product Status

Diagnostic Assay – Rheumatoid Arthritis – Product Description

SQI Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

ANA Ig_plex 11-Plex Assay – Product Status

ANA Ig_plex 11-Plex Assay – Product Description

Autoimmune Thyroid Panel 3-Plex Assay – Product Status

Autoimmune Thyroid Panel 3-Plex Assay – Product Description

Ig_plex 9-Plex – Product Status

Ig_plex 9-Plex – Product Description

Ig_PLEX Lupus Panel Assay – Product Status

Ig_PLEX Lupus Panel Assay – Product Description

IgX PLEX Celiac Panel 6-Plex Assay – Product Status

IgX PLEX Celiac Panel 6-Plex Assay – Product Description

Vasculitis Ig_PLEX 3-Plex – Product Status

Vasculitis Ig_PLEX 3-Plex – Product Description

Statens Serum Institut Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Test – Systemic Autoimmune Disease – Product Status

Diagnostic Test – Systemic Autoimmune Disease – Product Description

Sugentech Inc Pipeline Products & Ongoing Clinica

Figures

Auto-Immune Diseases – Pipeline Products by Stage of Development

Auto-Immune Diseases – Pipeline Products by Territory

Auto-Immune Diseases – Pipeline Products by Regulatory Path

Auto-Immune Diseases – Pipeline Products by Estimated Approval Date

Auto-Immune Diseases – Ongoing Clinical Trials

Frequently asked questions

Auto-Immune Diseases Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

Most Popular
$8,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Auto-Immune Diseases Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Auto-Immune Diseases reports
Medical Devices
New
United States Neuromodulation Devices Market Outlook to 2033 - Implantable…
$4,995 | February 2026
Medical Devices
New
United Kingdom Neuromodulation Devices Market Outlook to 2033 - Implantable…
$4,995 | February 2026
Medical Devices
New
Brazil Neuromodulation Devices Market Outlook to 2033 - Implantable Neuromodulation…
$4,995 | February 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Auto-Immune Diseases Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Auto-Immune Diseases Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more